Drug:
Reaction: PYREXIA
20260101 - 20261231
No. 401 - 500
| No. | safetyreportid |
occurcountry |
patientonsetage |
patientsex 1:M 2:F |
|---|---|---|---|---|
Adverse reaction |
||||
Drug (openfda.generic_name, medicinalproduct) |
||||
| 401 | 26518456 |
JP |
79 | 2 |
Malignant neoplasm progression, Pain of skin, Hypertension, Stomatitis, Dysphonia, Thrombocytopenia, Blood thyroid stimulating hormone increased, Arthralgia, Somnolence, Rash, Decreased appetite, Pyrexia, Malaise, Nausea, Diarrhoea, Vomiting, Thrombocytopenia, Hypothyroidism, Myocarditis, Inappropriate schedule of product administration, Inappropriate schedule of product administration, Inappropriate schedule of product administration, Inappropriate schedule of product administration, Inappropriate schedule of product administration, Inappropriate schedule of product administration, Inappropriate schedule of product administration, Inappropriate schedule of product administration, Inappropriate schedule of product administration, Inappropriate schedule of product administration, Inappropriate schedule of product administration, Inappropriate schedule of product administration, Inappropriate schedule of product administration, Inappropriate schedule of product administration, Inappropriate schedule of product administration, Inappropriate schedule of product administration, Inappropriate schedule of product administration, |
||||
PEMBROLIZUMAB, PEMBROLIZUMAB, PEMBROLIZUMAB, PEMBROLIZUMAB, PEMBROLIZUMAB, PEMBROLIZUMAB, PEMBROLIZUMAB, PEMBROLIZUMAB, PEMBROLIZUMAB, PEMBROLIZUMAB, PEMBROLIZUMAB, PEMBROLIZUMAB, PEMBROLIZUMAB, PEMBROLIZUMAB, PEMBROLIZUMAB, PEMBROLIZUMAB, PEMBROLIZUMAB, PEMBROLIZUMAB, PEMBROLIZUMAB, PEMBROLIZUMAB, PEMBROLIZUMAB, LENVATINIB, LENVATINIB, LENVATINIB, LENVATINIB, |
||||
| 402 | 26518638 |
EU |
21 | 1 |
Frequent bowel movements, Condition aggravated, Pyrexia, C-reactive protein increased, Gastrointestinal mucosal disorder, Enteritis, Colitis, Inappropriate schedule of product administration, Diarrhoea, Pyrexia, Abdominal pain, Gastrointestinal wall thickening, Aphthous ulcer, Gastrointestinal disorder, Intestinal stenosis, Colitis, Terminal ileitis, |
||||
ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, CIPROFLOXACIN, CIPROFLOXACIN HYDROCHLORIDE, CIPROFOLXACIN, CIPROFLOXACIN TABLETS, METRONIDAZOLE, METRONIDAZOLE TOPICAL, MESALAMINE, ISONIAZID, |
||||
| 403 | 26518661 |
MX |
||
Circulatory collapse, Multiple organ dysfunction syndrome, Septic shock, Pneumonia, Cardiac dysfunction, Neutropenia, Pyrexia, |
||||
DOXORUBICIN, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, |
||||
| 404 | 26518672 |
US |
58 | 2 |
Constipation, Nausea, Vomiting, Decreased appetite, Renal pain, Abdominal pain upper, Cough, Productive cough, Pyrexia, |
||||
EVEROLIMUS, EVEROLIMUS TABLETS, LENVATINIB, CABOZANTINIB, |
||||
| 405 | 26518761 |
EU |
4 | 2 |
Discomfort, Crying, Tremor, Tachycardia, Pyrexia, Cough, Vomiting, Off label use, |
||||
| 406 | 26518779 |
69 | 2 | |
Pyrexia, Headache, Catheter site erythema, Treatment delayed, |
||||
CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, CYTARABINE, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, DOXORUBICIN HYDROCHLORIDE, DOXORUBICIN, METHOTREXATE, METHOTREXATE SODIUM, VINCRISTINE SULFATE, |
||||
| 407 | 26518936 |
US |
2 | |
Pyrexia, Hypoaesthesia, Mobility decreased, Dysarthria, Gait inability, Aphasia, Weight decreased, Vision blurred, Rash, Dyspnoea, |
||||
ONABOTULINUMTOXINA, |
||||
| 408 | 26519328 |
EU |
2 | 1 |
Encephalitis, Meningism, Vomiting, Somnolence, Apathy, Pyrexia, |
||||
| 409 | 26519335 |
JP |
79 | 2 |
Rash erythematous, Diarrhoea, Decreased appetite, Swollen tongue, Pain, Chills, Pyrexia, Anal inflammation, |
||||
CAPIVASERTIB, CAPIVASERTIB, CAPIVASERTIB, FULVESTRANT, FULVESTRANT, BETAMETHASONE DIPROPIONATE, DENOSUMAB, METHYLPREDNISOLONE SODIUM SUCCINATE, LANSOPRAZOLE, FEXOFENADINE HYDROCHLORIDE, FEXOFENADINE HYDROCHLORIDE ORAL, FEXOFENADINE HCL, AZILSARTAN KAMEDOXOMIL, |
||||
| 410 | 26519632 |
CN |
74 | 1 |
Myelosuppression, Platelet count decreased, Pyrexia, |
||||
VENETOCLAX, VENETOCLAX, VENETOCLAX, VENETOCLAX, VENETOCLAX, VENETOCLAX, VENETOCLAX, VENETOCLAX, VENETOCLAX, VENETOCLAX, VENETOCLAX, VENETOCLAX, AZACITIDINE, AZACITIDINE FOR, AZACITIDINE, AZACITIDINE FOR, AZACITIDINE, AZACITIDINE FOR, AZACITIDINE, AZACITIDINE FOR, AZACITIDINE, AZACITIDINE FOR, AZACITIDINE, AZACITIDINE FOR, AZACITIDINE, AZACITIDINE FOR, AZACITIDINE, AZACITIDINE FOR, AZACITIDINE, AZACITIDINE FOR, AZACITIDINE, AZACITIDINE FOR, AZACITIDINE, AZACITIDINE FOR, AZACITIDINE, AZACITIDINE FOR, STERILE WATER FOR INJECTION, CYTARABINE, |
||||
| 411 | 26519802 |
US |
93 | 1 |
Pyrexia, Chills, Dyspnoea, Agitation, |
||||
FAMOTIDINE, |
||||
| 412 | 26519812 |
CA |
67 | 2 |
Neuropathy peripheral, Pyrexia, COVID-19, Blood pressure decreased, Condition aggravated, Synovial cyst, |
||||
RITUXIMAB-PVVR, RITUXIMAB-PVVR, RITUXIMAB-PVVR, RITUXIMAB-PVVR, RITUXIMAB-PVVR, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, DIPHENHYDRAMINE, DIPHENHYDRAMINE HYDROCHLORIDE, METHYLPREDNISOLONE, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, RIVAROXABAN, |
||||
| 413 | 26519991 |
CA |
1 | |
Immunosuppression, Pyrexia, Off label use, Bone marrow transplant, |
||||
ECULIZUMAB, AMOXICILLIN, |
||||
| 414 | 26520080 |
US |
||
Pyrexia, |
||||
CILTACABTAGENE AUTOLEUCEL, |
||||
| 415 | 26520196 |
US |
1 | |
Cough, Glassy eyes, Oropharyngeal pain, Pyrexia, |
||||
ELOSULFASE ALFA, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, EPINEPHRINE, ADRENALINUM, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN TABLET, FILM COATED, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, ALBUTEROL SULFATE, FLUTICASONE PROPIONATE, FLUTICASONE PROPIONATE NASAL, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, MONTELUKAST SODIUM, MONTELUKAST, DIPHENHYDRAMINE, DIPHENHYDRAMINE HYDROCHLORIDE, LIDOCAINE, HYDROCORTISONE SODIUM SUCCINATE, |
||||
| 416 | 26520224 |
EU |
63 | |
Disease progression, Metastases to liver, Jaundice, Pyrexia, Hepatic function abnormal, Therapeutic response decreased, Pyrexia, Rash, |
||||
TEBENTAFUSP, TEBENTAFUSP, |
||||
| 417 | 26520343 |
US |
12 | 2 |
Pyrexia, Product dose omission issue, |
||||
| 418 | 26520482 |
CN |
6 | 2 |
Rash, Pyrexia, Papule, |
||||
CYTARABINE, |
||||
| 419 | 26520491 |
GB |
70 | 1 |
Tremor, Pyrexia, |
||||
RITUXIMAB, |
||||
| 420 | 26520552 |
EU |
70 | 2 |
Stress cardiomyopathy, Pyrexia, Chest pain, Palpitations, |
||||
ZOLEDRONIC ACID, |
||||
| 421 | 26520614 |
EU |
70 | 2 |
Stress cardiomyopathy, Pyrexia, Chest pain, Palpitations, |
||||
ZOLEDRONIC ACID, |
||||
| 422 | 26520623 |
US |
||
Seizure, Underweight, Decreased appetite, Infection, Pyrexia, Myalgia, Arthralgia, Mobility decreased, Nausea, Drug specific antibody present, |
||||
RISANKIZUMAB-RZAA, INFLIXIMAB, VEDOLIZUMAB, GUSELKUMAB, |
||||
| 423 | 26520780 |
1 | ||
Stem cell transplant, Escherichia infection, Diarrhoea, Pyrexia, |
||||
REVUMENIB, |
||||
| 424 | 26520851 |
EU |
85 | 1 |
Cytokine release syndrome, Pyrexia, Thrombosis, Shock haemorrhagic, |
||||
IDECABTAGENE VICLEUCEL, |
||||
| 425 | 26520861 |
CA |
44 | 2 |
Anti-cyclic citrullinated peptide antibody positive, Arthralgia, Arthropathy, Joint swelling, Pregnancy, Pyrexia, Rash, Rheumatoid arthritis, Sinusitis, Synovitis, Weight increased, |
||||
OXYCODONE HYDROCHLORIDE, OXYCODONE, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN AND CODEINE, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, PREDNISONE, PREDNISONE, LEFLUNOMIDE, LEFLUNOMIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, APREPITANT, FOSAPREPITANT DIMEGLUMINE, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, FOLIC ACID, FOLIC ACID, FOLIC ACID, ALENDRONATE SODIUM, ADALIMUMAB, ADALIMUMAB, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, INFLIXIMAB, INFLIXIMAB, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, INFLIXIMAB, INFLIXIMAB, RITUXIMAB, ALENDRONATE SODIUM, ALENDRONATE SODIUM, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, OXYCODONE AND ACETAMINOPHEN, OXYCODONE HYDROCHLORIDE AND ACETAMINOPHEN, OXYCODONE AND ACETAMINOPHEN TABLETS, GOLIMUMAB, GOLIMUMAB, GOLIMUMAB, USTEKINUMAB, SULFAMETHOXAZOLE AND TRIMETHOPRIM, SULFAMETHOXAZOLE AND TRIMETHOPRIM, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, PREDNISONE, PREDNISONE, PREDNISONE, |
||||
| 426 | 26524647 |
81 | 2 | |
Pyrexia, Rash, |
||||
DOXYCYCLINE, DOXYCYCLINE HYCLATE, |
||||
| 427 | 26512190 |
US |
59 | 2 |
Feeling abnormal, Throat irritation, Pyrexia, Dizziness, Headache, Cough, |
||||
PANCRELIPASE, |
||||
| 428 | 26512232 |
JP |
64 | 1 |
Viral haemorrhagic cystitis, Cytomegalovirus infection reactivation, Cytokine release syndrome, Pyrexia, Therapeutic response unexpected, Potentiating drug interaction, Drug ineffective for unapproved indication, |
||||
EPCORITAMAB-BYSP, EPCORITAMAB-BYSP, EPCORITAMAB-BYSP, EPCORITAMAB-BYSP, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, DIPHENHYDRAMINE, DIPHENHYDRAMINE HYDROCHLORIDE, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, |
||||
| 429 | 26512250 |
CA |
2 | |
Arthralgia, Bone pain, Chills, Drug ineffective, Fatigue, Headache, Hypersensitivity, Migraine, Pain in extremity, Pyrexia, |
||||
HUMAN IMMUNOGLOBULIN G, |
||||
| 430 | 26512275 |
CA |
44 | 2 |
Wound, Drug ineffective, Drug intolerance, Fatigue, Glossodynia, Hand deformity, Hepatic enzyme increased, Inappropriate schedule of product administration, Intentional product misuse, Pain, Pemphigus, Pyrexia, Rash, Rheumatoid arthritis, Systemic lupus erythematosus, Therapeutic product effect decreased, Therapy non-responder, Treatment failure, |
||||
DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, PANTOPRAZOLE SODIUM, PANTOPRAZOLE SODIUM, PANTOPRAZOLE SODIUM, PANTOPRAZOLE SODIUM, OXYCODONE HYDROCHLORIDE, OXYCODONE, OXYCODONE HYDROCHLORIDE, OXYCODONE, OXYCODONE HYDROCHLORIDE, OXYCODONE, ALENDRONATE SODIUM, HYDROCORTISONE ACETATE, HYDROCORTISONE ACETATE, HYDROCORTISONE ACETATE, HYDROCORTISONE ACETATE, HYDROCORTISONE ACETATE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, MOXIFLOXACIN, MOXIFLOXACIN HYDROCHLORIDE, PREGABALIN, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, RAMIPRIL, DICLOFENAC, DICLOFENAC SODIUM, SECUKINUMAB, SECUKINUMAB, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, ISOPROPYL ALCOHOL, 70%ISOPROPYL ALCOHOL, ALCOHOL PREP PADS, ALCOHOL, ISOPROPYL ALCOHOL SPRAY, ISOPROPYL ALCOHOL, 70%ISOPROPYL ALCOHOL, ALCOHOL PREP PADS, ALCOHOL, ISOPROPYL ALCOHOL SPRAY, ISOPROPYL ALCOHOL, 70%ISOPROPYL ALCOHOL, ALCOHOL PREP PADS, ALCOHOL, ISOPROPYL ALCOHOL SPRAY, ISOPROPYL ALCOHOL, 70%ISOPROPYL ALCOHOL, ALCOHOL PREP PADS, ALCOHOL, ISOPROPYL ALCOHOL SPRAY, NEOMYCIN OINTMENT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, APREMILAST, APREMILAST, APREMILAST, APREMILAST, APREMILAST, APREMILAST, APREMILAST, INFLIXIMAB, INFLIXIMAB, GOLIMUMAB, GOLIMUMAB, GOLIMUMAB, GOLIMUMAB, GOLIMUMAB, GOLIMUMAB, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOFACITINIB CITRATE, TOFACITINIB CITRATE, TOFACITINIB CITRATE, TOFACITINIB CITRATE, TRAMADOL HYDROCHLORIDE, USTEKINUMAB, USTEKINUMAB, USTEKINUMAB, USTEKINUMAB, USTEKINUMAB, USTEKINUMAB, USTEKINUMAB, VITAMIN C, VITAMIN C, ERGOCALCIFEROL, ERGOCALCIFEROL, PREDNISONE, PREDNISONE, PREDNISONE, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, MINOCYCLINE HYDROCHLORIDE, MINOCYCLINE HYDROCHLORIDE, MINOCYCLINE HYDROCHLORIDE, |
||||
| 431 | 26512403 |
EU |
46 | 2 |
Intestinal perforation, Peritonitis, Trimethylaminuria, Megacolon, Pseudomembranous colitis, Clostridium difficile infection, Pyrexia, Urine odour abnormal, Oral discomfort, Condition aggravated, Bacterial test positive, White blood cells urine positive, Dysbiosis, Breath odour, Abdominal pain upper, Diarrhoea, Drug ineffective, Inhibitory drug interaction, Drug resistance, Drug interaction, |
||||
CEFUROXIME AXETIL, CEFUROXIME AXETIL, PANTOPRAZOLE, LEVOFLOXACIN, LEVOFLOXACIN IN 5% DEXTROSE, ARIPIPRAZOLE ORALLY DISINTEGRATING, ARIPIPRAZOLE, ARIPIPRAZOLE ORAL, CIPROFLOXACIN, CIPROFLOXACIN HYDROCHLORIDE, CIPROFOLXACIN, CIPROFLOXACIN TABLETS, CIPROFLOXACIN, CIPROFLOXACIN HYDROCHLORIDE, CIPROFOLXACIN, CIPROFLOXACIN TABLETS, SULFAMETHOXAZOLE AND TRIMETHOPRIM, OLANZAPINE, |
||||
| 432 | 26512415 |
US |
43 | 2 |
Pyrexia, Back pain, Dyspnoea, |
||||
PLOZASIRAN, RIVAROXABAN, FENOFIBRATE, PANTOPRAZOLE, SERTRALINE, PREGABALIN, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, NITROGLYCERIN, MECLIZINE HCL 12.5 MG, MECLIZINE HCL 25 MG, MECLIZINE HYDROCHLORIDE, MECLIZINE, MECLIZINE HCL 25MG, MECLIZINE HCL 12.5MG, TIOTROPIUM BROMIDE, ALBUTEROL SULFATE, INSULIN DEGLUDEC, INSULIN LISPRO, DAPAGLIFLOZIN, GEMFIBROZIL, ROSUVASTATIN, EZETIMIBE, PANCRELIPASE, CELECOXIB, TIZANIDINE, MIRABEGRON, SOLIFENACIN SUCCIATE, SOLIFENACIN SUCCINATE, FAMOTIDINE, ERGOCALCIFEROL, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, AMMONIUM LACTATE, POLYVINYL ALCOHOL, POVIDONE, |
||||
| 433 | 26512423 |
KR |
73 | 1 |
Ascites, Dyspnoea, Pyrexia, Off label use, |
||||
VALGANCICLOVIR HYDROCHLORIDE, VALGANCICLOVIR, VALGANCICLOVIR HYDROCHLORIDE POWDER,, ATEZOLIZUMAB, ATEZOLIZUMAB, ATEZOLIZUMAB, ATEZOLIZUMAB, ATEZOLIZUMAB, ATEZOLIZUMAB, BEVACIZUMAB, BEVACIZUMAB, BEVACIZUMAB, BEVACIZUMAB, BEVACIZUMAB, BEVACIZUMAB, VALSARTAN, AMLODIPINE, AMLODIPINE, TENOFOVIR DISOPROXIL FUMARATE, URSODIOL, URSOSIOL, MIRABEGRON, DESMOPRESSIN ACETATE, LIDOCAINE, LIDOCAINE HYDROCHLORIDE, BURN RELIEF, LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE, LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE, LIDOCAINE 4%, LIDOCAINE, MENTHOL, AZILSARTAN KAMEDOXOMIL AND CHLORTHALIDONE, BISOPROLOL FUMARATE, ALBUMIN HUMAN, |
||||
| 434 | 26512599 |
US |
2 | |
Pyrexia, |
||||
CILTACABTAGENE AUTOLEUCEL, |
||||
| 435 | 26512707 |
EU |
69 | 1 |
Cytokine release syndrome, Neutropenia, Pyrexia, Pancytopenia, Neuropathy peripheral, Cytomegalovirus infection reactivation, Pneumonia, |
||||
GLOFITAMAB, GEMCITABINE HYDROCHLORIDE, GEMCITABINE, OXALIPLATIN, AMLODIPINE BESYLATE, PROPRANOLOL HYDROCHLORIDE, |
||||
| 436 | 26512783 |
EU |
70 | 2 |
Pyrexia, Chest pain, Stress cardiomyopathy, Palpitations, |
||||
ZOLEDRONIC ACID, |
||||
| 437 | 26512835 |
EU |
74 | 2 |
Chills, Pyrexia, Headache, Arthralgia, Vitreous detachment, Conjunctival haemorrhage, |
||||
ZOLEDRONIC ACID, IVABRADINE, CLOPIDOGREL, CLOPIDOGREL BISULFATE, ESOMEPRAZOLE, ESOMEPRAZOLE MAGNESIUM, CALCIFEDIOL, |
||||
| 438 | 26512866 |
EU |
||
Fatigue, Hypertension, Decreased appetite, Weight decreased, Diarrhoea, Pruritus, Pyrexia, Aspartate aminotransferase increased, Alanine aminotransferase increased, Abdominal pain, Thrombocytopenia, Hypothyroidism, Proteinuria, Anaemia, Nausea, Vomiting, Epistaxis, Rash, Mucosal inflammation, Gastrointestinal haemorrhage, Haemorrhage, Intestinal varices haemorrhage, Embolism venous, Haemorrhoidal haemorrhage, Leukopenia, Arthralgia, Dysphonia, Embolism arterial, Hyperthyroidism, Immune-mediated enterocolitis, Dysgeusia, Skin ulcer, Immune-mediated lung disease, Palmar-plantar erythrodysaesthesia syndrome, Immune-mediated hepatitis, Cardiac failure, |
||||
ATEZOLIZUMAB, BEVACIZUMAB, |
||||
| 439 | 26512886 |
US |
32 | 1 |
Pyrexia, Chills, Nausea, Vomiting, Diarrhoea, Pain, Injection site infection, |
||||
TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, RIOCIGUAT, FAMOTIDINE, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, LOPERAMIDE HYDROCHLORIDE, FUROSEMIDE, SOTATERCEPT-CSRK, MACITENTAN, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, BUSPIRONE HYDROCHLORIDE, SPIRONOLACTONE, TRIAMCINOLONE ACETONIDE, TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05%, |
||||
| 440 | 26512936 |
US |
||
Pyrexia, Chills, Tremor, Headache, Nausea, Abdominal pain upper, Balance disorder, |
||||
RISANKIZUMAB-RZAA, |
||||
| 441 | 26512964 |
JP |
1 | |
Enterocolitis, Pyrexia, Abdominal pain, |
||||
| 442 | 26513031 |
US |
67 | 2 |
Pyrexia, Blister, Pain, Drug dose omission by device, |
||||
GALCANEZUMAB-GNLM, GALCANEZUMAB-GNLM, |
||||
| 443 | 26513050 |
US |
||
Pyrexia, |
||||
CABOTEGRAVIR AND RILPIVIRINE, CABOTEGRAVIR AND RILPIVIRINE, CABOTEGRAVIR AND RILPIVIRINE, |
||||
| 444 | 26513150 |
US |
1 | |
Pyrexia, Influenza, Malaise, Eye disorder, |
||||
RAVULIZUMAB, |
||||
| 445 | 26513169 |
EU |
55 | 2 |
Injection site abscess, Injection site infection, Pyrexia, Malaise, Injection site reaction, |
||||
FULVESTRANT, PALBOCICLIB, TRIPTORELIN, |
||||
| 446 | 26513812 |
EU |
1 | 2 |
Functional gastrointestinal disorder, Selective eating disorder, Syncope, Asthma, Vomiting, Dermatitis allergic, Sleep disorder, Headache, Respiratory tract infection, Abdominal pain, Immune system disorder, Pyrexia, Mood swings, Bradycardia, Hyperacusis, Restlessness, Abnormal behaviour, Impulsive behaviour, Aggression, Dizziness, Toe walking, Flatulence, Strabismus, Asthenia, Neurological symptom, Anxiety disorder, Vitiligo, Fatigue, Vaccination site oedema, Nervousness, Dyspepsia, Psychomotor hyperactivity, Hyperglycaemia, Decreased appetite, Nervous system disorder, Fungal infection, Irritability, Impatience, |
||||
| 447 | 26513829 |
CA |
73 | |
Paralysis, Dysuria, Condition aggravated, Fatigue, Pyrexia, Cough, Illness, Nasopharyngitis, Muscle spasms, Viral infection, Intentional dose omission, |
||||
ADALIMUMAB-AATY, ADALIMUMAB-AATY, NAPROXEN, NAPROXEN SODIUM, |
||||
| 448 | 26513885 |
1 | ||
Urinary retention, Hypertension, Tachycardia, Pyrexia, |
||||
NAXITAMAB, NAXITAMAB, |
||||
| 449 | 26513987 |
47 | 2 | |
Hot flush, Decreased appetite, Hyperhidrosis, Restlessness, Pyrexia, Retching, Gastrooesophageal reflux disease, Hiccups, Asthenia, Dysphoria, Depressed mood, Product prescribing issue, Device use issue, |
||||
LEVONORGESTREL, |
||||
| 450 | 26514120 |
US |
83 | 2 |
Pyrexia, Chills, Off label use, Adverse drug reaction, |
||||
AVATROMBOPAG MALEATE, ACETAMINOPHEN, |
||||
| 451 | 26514154 |
EU |
65 | 1 |
Disseminated intravascular coagulation, Hyperplasia, Pseudopolyp, Large intestinal ulcer, Colitis, Streptococcal infection, Gastrointestinal necrosis, Abdominal pain, Chills, Pyrexia, |
||||
ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, |
||||
| 452 | 26514547 |
GB |
1 | 1 |
Rash papular, Injection site swelling, Erythema, Injection site warmth, Pyrexia, Eczema, Injection site erythema, |
||||
| 453 | 26514598 |
US |
1 | |
Multiple sclerosis relapse, Pyrexia, Therapy interrupted, |
||||
DALFAMPRIDINE, |
||||
| 454 | 26514942 |
2 | ||
White blood cell count decreased, Infection, Pyrexia, |
||||
QUIZARTINIB, RUXOLITINIB, VENETOCLAX, |
||||
| 455 | 26514946 |
EU |
||
Ascites, Blindness, Cardio-respiratory arrest, Haemorrhagic stroke, Coma, Haematemesis, Amaurosis fugax, Altered state of consciousness, Arthralgia, Fall, Dizziness, Eye pain, Chills, Ocular discomfort, Tachycardia, Insomnia, Nausea, Fatigue, Dyspnoea, Diarrhoea, Head discomfort, Pruritus, Somnolence, Pyrexia, Haematuria, Presyncope, Vomiting, Malaise, Diplopia, Generalised oedema, Blood pressure increased, Cough, Headache, Myalgia, Urinary tract disorder, Decreased appetite, Photophobia, Abdominal pain, Tinnitus, Abdominal pain upper, Sepsis, |
||||
ANASTROZOLE, ANASTROZOLE TABLETS, PROPRANOLOL HYDROCHLORIDE, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, DUTASTERIDE, TAMSULOSIN HYDROCHLORIDE, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, VENLAFAXINE HYDROCHLORIDE, VENLAFAXINE, ALENDRONATE SODIUM, ESCITALOPRAM, ESCITALOPRAM OXALATE, ESCITSLOPRAM, IMATINIB MESYLATE, IMATINIB, HYDROCHLOROTHIAZIDE, PENTOXIFYLLINE, PRAVASTATIN SODIUM, EXEMESTANE, ENOXAPARIN SODIUM, BRINZOLAMIDE, FLUVASTATIN SODIUM, FLUVASTATIN, PITAVASTATIN CALCIUM, PITAVASTATIN, TOCILIZUMAB, INDOMETHACIN, NILOTINIB, EZETIMIBE, POTASSIUM IODIDE, PREGABALIN, FENOFIBRATE, DONEPEZIL HYDROCHLORIDE, ATORVASTATIN CALCIUM, ATORVASTATIN CALCIUM, FILM COATED, SERTRALINE HYDROCHLORIDE, TELMISARTAN, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ETANERCEPT, BUPRENORPHINE HYDROCHLORIDE, SOFOSBUVIR, LETROZOLE, LETROZOLE TABLETS, VERAPAMIL HYDROCHLORIDE, CELECOXIB, LEVOCETIRIZINE DIHYDROCHLORIDE, NITROGLYCERIN, HYDROMORPHONE HYDROCHLORIDE, SIMVASTATIN, IODINE, SERTRALINE, ALISKIREN HEMIFUMARATE, TRAMADOL HYDROCHLORIDE, DILTIAZEM HYDROCHLORIDE, DILTIAZEM HYDROCHLORIDE EXTENDED-RELEASE TABLETS, BISOPROLOL FUMARATE, VORTIOXETINE, RIBAVIRIN, ESCITALOPRAM OXALATE, ESCITALOPRAM, NITROGLYCERIN, |
||||
| 456 | 26515010 |
EU |
83 | 2 |
Toxic skin eruption, Pyrexia, Renal failure, Off label use, |
||||
CLINDAMYCIN HYDROCHLORIDE, CLINDAMYCIN HYDROCHLORIDE, METFORMIN HYDROCHLORIDE, METFORMIN, METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS, METFORMIN HYDROCHLORIDE TABLET, METFORMIN HYDROCHLORIDE TABLETS, |
||||
| 457 | 26515098 |
EU |
19 | 1 |
Thrombocytopenia, Respiratory syncytial virus infection, Nasopharyngitis, Pyrexia, Drug ineffective, |
||||
NIRSEVIMAB, |
||||
| 458 | 26515220 |
RS |
51 | 2 |
Cough, Pyrexia, Dyspnoea, Viral infection, |
||||
BENRALIZUMAB, BENRALIZUMAB, MONTELUKAST SODIUM, |
||||
| 459 | 26515266 |
KR |
80 | 2 |
Malignant neoplasm progression, Diffuse large B-cell lymphoma, Dyspnoea, Pyrexia, Tumour lysis syndrome, Cytokine release syndrome, Immune effector cell-associated neurotoxicity syndrome, Hypogammaglobulinaemia, Cytokine release syndrome, Diarrhoea, Pyrexia, |
||||
TISAGENLECLEUCEL, |
||||
| 460 | 26515322 |
CA |
59 | |
Blood pressure increased, Cough, Pneumonia, Pyrexia, Off label use, Intentional product use issue, |
||||
INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, |
||||
| 461 | 26515336 |
MX |
1 | |
Leukopenia, Myalgia, Arthralgia, Pyrexia, Diarrhoea, Steatorrhoea, Food intolerance, |
||||
ORAL SEMAGLUTIDE, |
||||
| 462 | 26515513 |
US |
58 | 2 |
Abdominal pain upper, Renal pain, Constipation, Nausea, Vomiting, Pyrexia, Productive cough, Decreased appetite, |
||||
EVEROLIMUS, EVEROLIMUS TABLETS, CABOZANTINIB, CABOZANTINIB, LENVATINIB, |
||||
| 463 | 26515914 |
55 | 1 | |
Heart rate increased, Blood pressure decreased, Nausea, Pyrexia, Chills, Fatigue, Discomfort, |
||||
LIFILEUCEL, ALDESLEUKIN, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, FLUDARABINE PHOSPHATE, ANAKINRA, |
||||
| 464 | 26516364 |
JP |
||
Pyrexia, |
||||
LECANEMAB, |
||||
| 465 | 26516432 |
CN |
57 | 1 |
Myelosuppression, Pyrexia, Neutropenia, |
||||
VENETOCLAX, VENETOCLAX, VENETOCLAX, VENETOCLAX, AZACITIDINE, AZACITIDINE FOR, STERILE WATER FOR INJECTION, |
||||
| 466 | 26516752 |
EU |
34 | 2 |
Abdominal pain, Hypoaesthesia, Pyrexia, Rash, |
||||
OXALIPLATIN, |
||||
| 467 | 26507643 |
EU |
56 | 2 |
Endocarditis, Lactobacillus bacteraemia, Pyrexia, |
||||
BEVACIZUMAB-AWWB, TRIFLURIDINE AND TIPIRACIL, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, ESTRIOL0.2%, ESTRIOL, OXYCODONE HYDROCHLORIDE, OXYCODONE, METOCLOPRAMIDE, METOCLOPRAMIDE HYDROCHLORIDE, |
||||
| 468 | 26507678 |
CN |
||
Pneumonitis, Drug-induced liver injury, Upper respiratory tract infection, Pyrexia, Hypersensitivity, White blood cell count decreased, Alanine aminotransferase increased, Gastrointestinal infection, |
||||
ECULIZUMAB, |
||||
| 469 | 26507763 |
US |
57 | 2 |
Hallucination, Pyrexia, Sinusitis, |
||||
ADALIMUMAB, |
||||
| 470 | 26507776 |
EU |
70 | 2 |
Respiratory tract infection, Blood loss anaemia, Diarrhoea, Pyrexia, |
||||
UPADACITINIB, UPADACITINIB, |
||||
| 471 | 26508107 |
US |
||
Pyrexia, Headache, |
||||
OCRELIZUMAB, |
||||
| 472 | 26508138 |
EU |
2 | |
Tachycardia, Dyspnoea, General physical health deterioration, Pyrexia, |
||||
METHOTREXATE, METHOTREXATE SODIUM, LEFLUNOMIDE, RIBOCICLIB, |
||||
| 473 | 26508227 |
US |
8 | 1 |
Asthma, Dermatitis atopic, Pyrexia, Hyperhidrosis, Sleep disorder due to a general medical condition, |
||||
DUPILUMAB, |
||||
| 474 | 26508337 |
GN |
33 | 2 |
Ascites, Vomiting, Alopecia, Anorectal disorder, Herpes zoster, Escherichia infection, Weight decreased, Pyrexia, |
||||
PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, DOXORUBICIN HYDROCHLORIDE, DOXORUBICIN, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, |
||||
| 475 | 26508345 |
CO |
23 | 1 |
Hypokalaemia, Insomnia, Gastroenteritis, Urinary tract discomfort, Diarrhoea, Pain, Headache, Feeling of body temperature change, Influenza like illness, Pyrexia, Malaise, Weight decreased, Hypochromic anaemia, Alopecia, Pallor, Dry skin, Pain of skin, Dysuria, Hyperaesthesia, Proteinuria, Sneezing, Headache, Nausea, Palpitations, Dyspnoea, Abdominal pain, Somnolence, Asthenia, Erythema, Malaise, Malaise, Malaise, Body temperature increased, Chills, Pyrexia, Oropharyngeal pain, Cough, Rhinitis, Pain in extremity, Fatigue, Headache, Paraesthesia, Back pain, Hypotension, Tachycardia, Asthenia, Off label use, |
||||
AGALSIDASE BETA, AGALSIDASE BETA, AGALSIDASE BETA, HYDROXYZINE, |
||||
| 476 | 26508362 |
IN |
2 | |
Typhoid fever, Pyrexia, |
||||
OLAPARIB, CALCIUM, |
||||
| 477 | 26508389 |
CA |
73 | 1 |
Clostridium difficile colitis, Neutrophil count increased, Pyrexia, |
||||
CIPROFLOXACIN, CIPROFLOXACIN HYDROCHLORIDE, CIPROFOLXACIN, CIPROFLOXACIN TABLETS, CEFIXIME, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, BISACODYL, BISACODYL SUPPOSITORIES, BISCODYL, CLONAZEPAM, FENTANYL, GLYCERIN, GLYCERIN SUPPOSITORIES, LIDOCAINE, LIDOCAINE HYDROCHLORIDE, BURN RELIEF, LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE, LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE, LIDOCAINE 4%, LIDOCAINE, MENTHOL, METHADONE, PANTOPRAZOLE, POLYETHYLENE GLYCOL, |
||||
| 478 | 26508399 |
CA |
28 | 2 |
Metabolic acidosis, Dehydration, Intestinal dilatation, Clostridium difficile colitis, Pyrexia, Diarrhoea, |
||||
LEVOFLOXACIN, LEVOFLOXACIN IN 5% DEXTROSE, CICLESONIDE, ALBUTEROL SULFATE, ALBUTEROL, |
||||
| 479 | 26508491 |
US |
38 | 2 |
Angiocentric lymphoma, Pseudomonas infection, Haemophagocytic lymphohistiocytosis, Pyrexia, Off label use, |
||||
PREDNISONE, RITUXIMAB, ISONIAZID, RIFAMPIN, PYRAZINAMIDE, MOXIFLOXACIN, MOXIFLOXACIN HYDROCHLORIDE, ETOPOSIDE, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, DOXORUBICIN, METHOTREXATE, METHOTREXATE SODIUM, |
||||
| 480 | 26508517 |
CN |
85 | 1 |
Pyrexia, |
||||
ISAVUCONAZONIUM SULFATE, |
||||
| 481 | 26508671 |
CN |
65 | 2 |
Temperature intolerance, Chills, Off label use, Pyrexia, |
||||
OBINUTUZUMAB, OBINUTUZUMAB, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, |
||||
| 482 | 26508692 |
CA |
44 | 2 |
Rash, Pruritus, Pyrexia, Drug hypersensitivity, Rheumatic fever, Rheumatoid arthritis, Rheumatoid factor positive, Road traffic accident, Sinusitis, Sleep disorder, Sleep disorder due to general medical condition, insomnia type, Stomatitis, Swelling, Swollen joint count increased, Synovitis, Systemic lupus erythematosus, Therapeutic product effect decreased, Therapy non-responder, Treatment failure, Type 2 diabetes mellitus, Urticaria, Vomiting, Weight increased, Wheezing, Wound, Alopecia, Anti-cyclic citrullinated peptide antibody positive, Blister, Decreased appetite, Discomfort, |
||||
SECUKINUMAB, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, OXYCODONE, OXYCODONE, OXYCODONE HYDROCHLORIDE, OXYCODONE, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, ADALIMUMAB-ADAZ, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, OXYCODONE AND ACETAMINOPHEN, OXYCODONE HYDROCHLORIDE AND ACETAMINOPHEN, OXYCODONE AND ACETAMINOPHEN TABLETS, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, VITAMIN C, CALCIUM CARBONATE, ANTACID, |
||||
| 483 | 26508813 |
JP |
65 | |
Urinary retention, Cytokine release syndrome, Hypotension, Pyrexia, COVID-19, COVID-19, Intentional product use issue, |
||||
AXICABTAGENE CILOLEUCEL, |
||||
| 484 | 26508816 |
JP |
50 | |
Follicular lymphoma, Campylobacter bacteraemia, Cytokine release syndrome, Immune effector cell-associated neurotoxicity syndrome, Hypoxia, Hypotension, Pyrexia, Dysgraphia, Tremor, |
||||
AXICABTAGENE CILOLEUCEL, |
||||
| 485 | 26508818 |
JP |
62 | |
Pneumonia bacterial, Cytokine release syndrome, Immune effector cell-associated neurotoxicity syndrome, Myoclonus, Movement disorder, Liver disorder, Soft tissue inflammation, Pyrexia, COVID-19, Sinusitis, Rash, |
||||
AXICABTAGENE CILOLEUCEL, |
||||
| 486 | 26508824 |
US |
49 | 2 |
Nasal congestion, Viral infection, Pyrexia, Fatigue, Headache, Lacrimation increased, Oropharyngeal pain, |
||||
TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, METHOCARBAMOL, METHOCARBAMOL TABLETS, DEXTROMETHORPHAN HYDROBROMIDE AND GUAIFENESIN, DEXTROMETHORPHAN, ACETAMINOPHEN AND DEXTROMETHORPHAN HYDROBROMIDE, METOPROLOL TARTRATE, METOROPROLOL TARTRATE, METOPROLOL, VITAMIN C, ATORVASTATIN CALCIUM, ATORVASTATIN CALCIUM, FILM COATED, LACTULOSE, EZETIMIBE, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, METOCLOPRAMIDE HYDROCHLORIDE, PROMETHAZINE HYDROCHLORIDE, ERGOCALCIFEROL, MACITENTAN, SPIRONOLACTONE, FUROSEMIDE, ZINC, ZINC GLUCONATE, ZINC CHLORIDE, GUAIFENESIN AND DEXTROMETHORPHAN HYDROBROMIDE, SCOPOLAMINE, OXYGEN, 0XYGEN, TIRZEPATIDE, FAMOTIDINE, EVOLOCUMAB, MIDODRINE HYDROCHLORIDE, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, |
||||
| 487 | 26509176 |
JP |
71 | |
Staphylococcal bacteraemia, Cytokine release syndrome, Pyrexia, Platelet count decreased, Neutrophil count decreased, |
||||
AXICABTAGENE CILOLEUCEL, |
||||
| 488 | 26509230 |
JP |
6 | |
Cytomegalovirus viraemia, Cytokine release syndrome, Neutrophil count decreased, Pyrexia, |
||||
AXICABTAGENE CILOLEUCEL, TOCILIZUMAB, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, FLUDARABINE PHOSPHATE, FLUDARABINE PHOSPHATE, |
||||
| 489 | 26509290 |
JP |
6 | |
Cytomegalovirus viraemia, Cytokine release syndrome, Neutrophil count decreased, Pyrexia, |
||||
AXICABTAGENE CILOLEUCEL, |
||||
| 490 | 26509332 |
MX |
10 | 1 |
Neutropenia, Anaemia, Pyrexia, |
||||
DOXORUBICIN, GEMCITABINE HYDROCHLORIDE, GEMCITABINE, |
||||
| 491 | 26509498 |
CN |
||
Neutropenia, Febrile neutropenia, Thrombocytopenia, Sepsis, Respiratory tract infection, Stomatitis, Gastrointestinal infection, Pyrexia, |
||||
CARFILZOMIB, FILGRASTIM, LENALIDOMIDE, DARATUMUMAB, ETOPOSIDE, CYTARABINE, |
||||
| 492 | 26510110 |
CA |
61 | 2 |
Pneumonia, Pyrexia, Sensitive skin, Injection site erythema, |
||||
DUPILUMAB, DUPILUMAB, DUPILUMAB, ALBUTEROL SULFATE, LEVOTHYROXINE SODIUM, FLUTICASONE FUROATE AND VILANTEROL TRIFENATATE, |
||||
| 493 | 26510155 |
CN |
||
Pyrexia, Pneumonitis, Diarrhoea, Nausea, Vomiting, Blood glucose increased, Blood pressure increased, Off label use, |
||||
RITUXIMAB, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, CYCLOSPORINE, |
||||
| 494 | 26510210 |
EU |
||
Thrombocytopenia, Pyrexia, Malaise, Chills, Multiple use of single-use product, Off label use, Off label use, |
||||
ORITAVANCIN, ORITAVANCIN, AMPICILLIN, AMPICILLIN SODIUM, AMPICILLIN INJECTION, GENTAMICIN, GENTAMICIN SULFATE, DAPTOMYCIN, CEFTRIAXONE, CEFTRIAXONE SODIUM, |
||||
| 495 | 26510230 |
JP |
61 | |
Diffuse large B-cell lymphoma, Cytokine release syndrome, Hypoxia, Pyrexia, |
||||
AXICABTAGENE CILOLEUCEL, |
||||
| 496 | 26510280 |
JP |
7 | 2 |
Cataract, Uveitis, Dysphagia, Vomiting, Pyrexia, Vitreous floaters, |
||||
ENCORAFENIB, ENCORAFENIB, ENCORAFENIB, ENCORAFENIB, BINIMETINIB, BINIMETINIB, BINIMETINIB, BINIMETINIB, |
||||
| 497 | 26510352 |
US |
||
Pyrexia, Fatigue, Lung disorder, |
||||
IVACAFTOR, |
||||
| 498 | 26510359 |
US |
||
Pyrexia, |
||||
CABOTEGRAVIR AND RILPIVIRINE, CABOTEGRAVIR AND RILPIVIRINE, |
||||
| 499 | 26510381 |
GB |
32 | 1 |
Abscess limb, Peripheral swelling, Erythema, Pyrexia, |
||||
RISANKIZUMAB-RZAA, MOMETASONE, |
||||
| 500 | 26510427 |
IN |
67 | 1 |
Tuberculosis, Pyrexia, |
||||
disclaimer
Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.
terms
license
last_updated
2026-04-28
